Literature DB >> 7110116

Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.

M Waelbroeck, P Robberecht, P Chatelain, J Christophe.   

Abstract

The binding properties of muscarinic cholinergic binding sites were investigated in rat cardiac membranes, using the labeled agonist [3H] oxotremorine-M ([3H]Oxo-M) and the labeled antagonist L-[benzilic-4,4'-3H]quinuclidinyl benzilate (L-[3H]QNB). The binding of both tracers was inhibited stereospecifically by dexetimide and levitimide. [3H]Oxo-M labeled only high-affinity agonist binding sites, whereas L-[3H]QNB bound to high- and low-affinity agonist binding sites with equal affinity. Agonists were unable to induce "negative cooperativity" interactions by increasing the dissociation of labeled agonist or antagonist. Guanine nucleotides decreased markedly the affinity of high- and low-affinity binding sites for agonists, without affecting their affinity for antagonists. In the presence of a maximally effective concentration of GTP, all muscarinic receptors showed the same low affinity for agonists. Among these agonists, carbamylcholine and oxotremorine (but not pilocarpine) displayed a lower affinity for both classes of binding sites in the presence of GTP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110116

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  25 in total

1.  Muscarinic cholinoceptors in the human heart: demonstration, subclassification, and distribution.

Authors:  N M Deighton; S Motomura; D Borquez; H R Zerkowski; N Doetsch; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

2.  Propylbenzilylcholine mustard is selective for rat heart muscarinic receptors having a low affinity for agonists.

Authors:  J Christophe; P De Neef; P Robberecht; M Waelbroeck
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

3.  Reconstitution of solubilized atrial cholinergic muscarinic receptors in liposomes.

Authors:  J S Aguilar; E L Ochoa; E De Robertis
Journal:  Neurochem Res       Date:  1987-01       Impact factor: 3.996

4.  Modulation of agonist binding by guanine nucleotides in CHO cells expressing muscarinic m1-m5 receptors.

Authors:  P L van Giersbergen; R Leppik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

5.  Evidence for two modes of Ca2+ entry following muscarinic stimulation of a human salivary epithelial cell line.

Authors:  X J He; X Z Wu; R J Turner; B J Baum
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

6.  Discrimination by N-ethylmaleimide between the chronotropic and inotropic response to muscarinic receptor stimulation in rat atrium.

Authors:  H N Doods; D Davidesko; M J Mathy; H D Batink; A de Jonge; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

7.  Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors.

Authors:  Eyup Akgün; Meike Körner; Fan Gao; Kaleeckal G Harikumar; Beatrice Waser; Jean Claude Reubi; Philip S Portoghese; Laurence J Miller
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

8.  A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart.

Authors:  M Delhaye; J M De Smet; G Taton; P De Neef; J C Camus; J Fontaine; M Waelbroeck; P Robberecht; J Christophe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

9.  The effects of agonists on the components of the cardiac muscarinic receptor.

Authors:  A S Burgen
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

10.  Recognition of the muscarinic receptor by its endogenous neurotransmitter: binding of [3H]acetylcholine and its modulation by transition metal ions and guanine nucleotides.

Authors:  D Gurwitz; Y Kloog; M Sokolovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.